Quality control of Papanicolaou tests
DOI:
https://doi.org/10.5327/2237-4574-2024810001Keywords:
Papanicolaou, cytology, quality controlAbstract
The Papanicolaou test, or oncotic cytology, is a screening test used to detect precancerous lesions in the cervix. Its accuracy depends on variables such as sample collection, fixation, staining, and smear reading. The collection and fixation are the responsibility of the professional performing the test, while staining and smear reading are the laboratory's responsibility. Since reading is subjective, quality control is critical. Internal practices include cytologic-histologic correlation, review by experienced professionals, and retrospective re-evaluation of high-grade lesions. External quality control is conducted by specialized associations or services accredited by the Ministry of Health, through rechecks and online evaluations. In addition to quality control, ongoing education is essential to maintain the test's accuracy. The quality of the Papanicolaou test relies on proper collection, correct analysis, and an adequate laboratory setup. Successful screening also requires an organized follow-up after the cytological diagnosis.
References
Bibbo M, Keeber CM. Diagnostic quality assurance in cytopathology. In: Biboo M, Wilbur D. Comprehensive cytopathology. 4th Ed. London: Elsevier; 2015. p. 59-64.
Costa RFA, Longatto-Filho A, Pinheiro C, Zeferino LC, Fregnani JH. Historical analysis of the Brazilian Cervical Cancer Screening Program from 2006 to 2013: a time for reflection. PLoS One. 2015;10(9):e0138945. https://doi.org/10.1371/journal.pone.0138945
Queiroz Filho J, Eleutério Jr J, Cobucci RN, Crispim JCO, Giraldo PC, Gonçalves AK. Does 100% rapid review improve cervical cancer screening? Acta Cytol. 2018;62(3):209-14. https://doi.org/10.1159/000488872
Spence AR, Goggin P, Franco EL. Process of care failures in invasive cervical cancer: Systematic review and meta-analysis. Prev Med. 2007;45(2-3):93-106. https://doi.org/10.1016/j.ypmed.2007.06.007